Korro Bio, INC 8-K filings

NASDAQ

22 Apr 2024

KRRO

8-K: Korro Bio Completes $70 Million Private Placement to Advance Pipeline

Korro Bio successfully closed a $70 million private placement, led by Deep Track Capital, to fund clinical trials and platform development.

NASDAQ

18 Apr 2024

KRRO

Korro Bio, INC

8-K: Korro Bio Secures $70 Million in Private Placement to Advance RNA Editing Pipeline

Korro Bio has successfully raised $70 million through a private placement to fund its clinical programs and platform development.

NASDAQ

26 Mar 2024

KRRO

Korro Bio, INC

8-K: Korro Bio Reports Full Year 2023 Financial Results and Highlights Pipeline Progress

Korro Bio announced its full year 2023 financial results, highlighting a strong cash position and advancements in its RNA editing platform and pipeline, including a regulatory filing for its lead candidate expected in the second half of 2024.